ATE162073T1 - Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol - Google Patents
Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumolInfo
- Publication number
- ATE162073T1 ATE162073T1 AT95105766T AT95105766T ATE162073T1 AT E162073 T1 ATE162073 T1 AT E162073T1 AT 95105766 T AT95105766 T AT 95105766T AT 95105766 T AT95105766 T AT 95105766T AT E162073 T1 ATE162073 T1 AT E162073T1
- Authority
- AT
- Austria
- Prior art keywords
- xanthohumole
- treatment
- pharmaceutical composition
- osteoporosis
- osteoporosis containing
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 abstract 2
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 abstract 2
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 abstract 2
- 235000008209 xanthohumol Nutrition 0.000 abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6082852A JPH07285856A (ja) | 1994-04-21 | 1994-04-21 | 骨粗鬆症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE162073T1 true ATE162073T1 (de) | 1998-01-15 |
Family
ID=13785904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95105766T ATE162073T1 (de) | 1994-04-21 | 1995-04-18 | Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5679716A (ko) |
| EP (1) | EP0679393B1 (ko) |
| JP (1) | JPH07285856A (ko) |
| KR (1) | KR100350564B1 (ko) |
| AT (1) | ATE162073T1 (ko) |
| AU (1) | AU695696B2 (ko) |
| CA (1) | CA2147419A1 (ko) |
| DE (1) | DE69501419T2 (ko) |
| DK (1) | DK0679393T3 (ko) |
| ES (1) | ES2116642T3 (ko) |
| FI (1) | FI951856A (ko) |
| HU (1) | HUT71603A (ko) |
| NO (1) | NO951498L (ko) |
| TW (1) | TW284687B (ko) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008208A (en) * | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
| DE19939350B4 (de) * | 1999-08-19 | 2005-04-07 | Plantextrakt Gmbh & Co. Kg | Hopfenextrakt und Verfahren zu dessen Herstellung |
| KR20060095786A (ko) * | 2000-01-27 | 2006-09-01 | 다카라 바이오 가부시키가이샤 | 치료제 |
| US20040002423A1 (en) * | 2000-04-10 | 2004-01-01 | Hiromu Ohnogi | Remedies |
| US6352726B1 (en) * | 2001-01-09 | 2002-03-05 | S. S. Steiner, Inc. | Method of killing protozoa |
| BR0208418A (pt) * | 2001-04-05 | 2004-03-30 | Unilever Nv | Uso de isoxantohumol e/ou xantohumol, método para administrar isoxantohumol e/ou xantohumol a seres humanos em necessidade de receber um componente ani-inflamatório ou anti-envelhecimento, e, produto alimentìcio |
| FR2823672B1 (fr) * | 2001-04-23 | 2004-03-12 | Berkem Sa | Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes |
| KR100993113B1 (ko) * | 2002-02-14 | 2010-11-08 | 기린 홀딩스 가부시키가이샤 | 지질대사 개선용 조성물 및 식품 |
| AU2002257721A1 (en) * | 2002-04-24 | 2003-11-10 | Unilever Plc | Use of hop components in foods |
| DE10240065B4 (de) * | 2002-08-30 | 2004-10-28 | Hallertauer Hopfenveredlungsgesellschaft M.B.H. | Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt |
| DK1431385T3 (da) * | 2002-12-18 | 2006-07-31 | Doehler Gmbh | Xanthohumolholdig drik |
| ATE407667T1 (de) * | 2003-04-08 | 2008-09-15 | Kirin Brewery | Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte |
| DE102004063125B4 (de) | 2004-12-22 | 2007-03-15 | Ta-Xan-Ag | Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke |
| CA2617209A1 (en) * | 2005-07-29 | 2007-02-08 | Bioactives, Inc. | Prenylflavonoid formulations |
| DE102006062264A1 (de) * | 2006-12-22 | 2008-06-26 | Joh. Barth & Sohn Gmbh & Co. Kg | Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen |
| EP2392325A1 (en) | 2010-06-04 | 2011-12-07 | Universitätsklinikum Münster | Compounds for the prevention and/or treatment of osteoarthrosis |
| KR101323150B1 (ko) * | 2011-04-25 | 2013-10-30 | 충남대학교산학협력단 | 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물 |
| CN103371989A (zh) * | 2012-04-24 | 2013-10-30 | 华东师范大学 | 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用 |
| DK2877167T3 (da) * | 2012-07-26 | 2020-10-12 | Arcaini Antonio | Anvendelse af sammensætninger indeholdende et ristet ekstrakt og xanthohumol |
| JP6009498B2 (ja) * | 2014-06-24 | 2016-10-19 | 国立大学法人京都大学 | アルツハイマー病予防薬 |
| US20180193287A1 (en) | 2015-07-02 | 2018-07-12 | John I. Haas, Inc. | Hops-based substance and use of the substance |
| CN105477686B (zh) * | 2015-11-30 | 2019-02-15 | 长春工业大学 | 一种包覆黄腐酚的纳米纤维膜 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3794744A (en) * | 1972-05-10 | 1974-02-26 | White Tomkins Ltd | Purification of hop extracts |
| US4065574A (en) * | 1975-08-29 | 1977-12-27 | The Upjohn Company | New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds |
-
1994
- 1994-04-21 JP JP6082852A patent/JPH07285856A/ja active Pending
-
1995
- 1995-04-18 ES ES95105766T patent/ES2116642T3/es not_active Expired - Lifetime
- 1995-04-18 AT AT95105766T patent/ATE162073T1/de not_active IP Right Cessation
- 1995-04-18 DE DE69501419T patent/DE69501419T2/de not_active Expired - Fee Related
- 1995-04-18 DK DK95105766T patent/DK0679393T3/da active
- 1995-04-18 EP EP95105766A patent/EP0679393B1/en not_active Expired - Lifetime
- 1995-04-19 FI FI951856A patent/FI951856A/fi unknown
- 1995-04-19 KR KR1019950009173A patent/KR100350564B1/ko not_active IP Right Cessation
- 1995-04-19 AU AU16535/95A patent/AU695696B2/en not_active Ceased
- 1995-04-20 NO NO951498A patent/NO951498L/no not_active Application Discontinuation
- 1995-04-20 HU HU9501121A patent/HUT71603A/hu unknown
- 1995-04-20 CA CA002147419A patent/CA2147419A1/en not_active Abandoned
- 1995-05-10 TW TW084104612A patent/TW284687B/zh active
-
1996
- 1996-09-27 US US08/720,004 patent/US5679716A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2116642T3 (es) | 1998-07-16 |
| TW284687B (ko) | 1996-09-01 |
| HU9501121D0 (en) | 1995-06-28 |
| FI951856A0 (fi) | 1995-04-19 |
| US5679716A (en) | 1997-10-21 |
| AU695696B2 (en) | 1998-08-20 |
| DE69501419D1 (de) | 1998-02-19 |
| AU1653595A (en) | 1995-10-19 |
| EP0679393A3 (en) | 1995-11-15 |
| DK0679393T3 (da) | 1998-09-14 |
| EP0679393B1 (en) | 1998-01-14 |
| NO951498L (no) | 1995-10-23 |
| KR950031060A (ko) | 1995-12-18 |
| JPH07285856A (ja) | 1995-10-31 |
| KR100350564B1 (ko) | 2002-12-16 |
| NO951498D0 (no) | 1995-04-20 |
| EP0679393A2 (en) | 1995-11-02 |
| DE69501419T2 (de) | 1998-06-25 |
| HUT71603A (en) | 1996-01-29 |
| CA2147419A1 (en) | 1995-10-22 |
| FI951856A (fi) | 1995-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69501419D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol | |
| ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| DE69732170D1 (de) | Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan | |
| DE69034148D1 (de) | Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie | |
| DE69507185D1 (de) | Arzneimittel zur Behandlung von Osteoporose | |
| ES2181017T3 (es) | Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| DE69426530D1 (de) | Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz | |
| DE69314586D1 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| DE69424747T2 (de) | Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen | |
| DE69915852D1 (de) | Lhrh-analoga zur behandlung der osteoporose | |
| UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
| ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
| UA30143C2 (uk) | Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань | |
| UA13401C2 (uk) | Ветеринарний препарат для профілактики та лікування хвороб вірусної та бактеріальної природи |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |